Putnam BioRevolution ETF (SYNB)

Assets	$5.06M
Expense Ratio	0.71%
PE Ratio	28.45
Shares Out	175,000
Dividend (ttm)	$0.21
Dividend Yield	0.73%
Ex-Dividend Date	Dec 5, 2024
Payout Frequency	Annual
Payout Ratio	20.71%

Volume	1
Open	29.39
Previous Close	29.14
Day's Range	29.39 - 29.39
52-Week Low	24.57
52-Week High	33.23
Beta	0.94
Holdings	35
Inception Date	Sep 29, 2022

About SYNB

Fund Home Page

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is issued by Putnam.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: SYNB
• ETF Provider: Putnam

Top 10 Holdings

50.72% of assets

Name	Symbol	Weight
Thermo Fisher Scientific Inc.	TMO	6.92%
Corteva, Inc.	CTVA	6.38%
Novozymes A/S	NVZMY	6.09%
AbbVie Inc.	ABBV	5.19%
Bio-Rad Laboratories, Inc.	BIO	4.80%
NVIDIA Corporation	NVDA	4.75%
AstraZeneca PLC	AZN	4.46%
Ascendis Pharma A/S	ASND	4.29%
Zoetis Inc.	ZTS	4.03%
Eli Lilly and Company	LLY	3.82%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 5, 2024	$0.2139	Dec 9, 2024
Dec 6, 2023	$0.0211	Dec 11, 2023

Performance

SYNB had a total return of -5.13% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.61%.